NYSE:MTD - Mettler-Toledo International Stock Price, Price Target & More

Mettler-Toledo International trades on the New York Stock Exchange (NYSE) under the ticker symbol "MTD."

Mettler-Toledo International Inc. (NYSE:MTD) issued its earnings results on Thursday, May, 3rd. The medical instruments supplier reported $3.74 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $3.73 by $0.01. The medical instruments supplier earned $660.82 million during the quarter, compared to analyst estimates of $651.87 million. Mettler-Toledo International had a net margin of 13.50% and a return on equity of 90.70%. The business's revenue was up 11.1% on a year-over-year basis. During the same period in the previous year, the firm earned $3.34 earnings per share. View Mettler-Toledo International's Earnings History.

Mettler-Toledo International is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Mettler-Toledo International.

Mettler-Toledo International issued an update on its second quarter earnings guidance on Thursday, May, 3rd. The company provided EPS guidance of $4.55 to $4.60 for the period, compared to the Thomson Reuters consensus estimate of $4.54.

10 analysts have issued 1 year price objectives for Mettler-Toledo International's shares. Their predictions range from $540.00 to $692.00. On average, they anticipate Mettler-Toledo International's share price to reach $628.00 in the next twelve months. This suggests a possible upside of 7.7% from the stock's current price. View Analyst Ratings for Mettler-Toledo International.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mettler-Toledo International in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Mettler-Toledo International include Illumina (ILMN), Agilent Technologies (A), Waters (WAT), Bio-Rad Laboratories, Inc. Class A Common Stock (BIO), Bio-Rad Laboratories, Inc. Class B (BIO.B), PerkinElmer (PKI), Integra Lifesciences (IART), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM) and Harvard Bioscience (HBIO).

Media coverage about MTD stock has trended somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Mettler-Toledo International earned a news sentiment score of 0.11 on Accern's scale. They also gave press coverage about the medical instruments supplier an impact score of 45.17 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Mettler-Toledo International's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Legacy Private Trust Co. (0.03%), Fjarde AP Fonden Fourth Swedish National Pension Fund (0.03%), Xact Kapitalforvaltning AB (0.02%), State of Alaska Department of Revenue (0.02%), CENTRAL TRUST Co (0.01%) and Atria Investments LLC (0.01%). Company insiders that own Mettler-Toledo International stock include Christian Magloth, Francis A Contino, Hans Ulrich Maerki, La Guerroniere Marc De, Michael A Kelly, Michael Heidingsfelder, Oliver A Filliol, Richard D Francis, Robert F Spoerry, Shawn Vadala, Simon Kirk, Thomas Caratsch, Thomas P Salice, Wah-Hui Chu, Waldemar Rauch and William P Donnelly. View Institutional Ownership Trends for Mettler-Toledo International.

MTD stock was sold by a variety of institutional investors in the last quarter, including Legacy Private Trust Co., State of Alaska Department of Revenue, CENTRAL TRUST Co and Gateway Investment Advisers LLC. Company insiders that have sold Mettler-Toledo International company stock in the last year include Christian Magloth, La Guerroniere Marc De, Michael A Kelly, Michael Heidingsfelder, Oliver A Filliol, Robert F Spoerry, Shawn Vadala, Simon Kirk, Thomas Caratsch, Thomas P Salice, Wah-Hui Chu, Waldemar Rauch and William P Donnelly. View Insider Buying and Selling for Mettler-Toledo International.

MTD stock was bought by a variety of institutional investors in the last quarter, including Fjarde AP Fonden Fourth Swedish National Pension Fund, IFM Investors Pty Ltd, Xact Kapitalforvaltning AB and Atria Investments LLC. View Insider Buying and Selling for Mettler-Toledo International.

Shares of MTD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MTD stock can currently be purchased for approximately $583.13.

Mettler-Toledo International has a market capitalization of $14.81 billion and generates $2.73 billion in revenue each year. The medical instruments supplier earns $375.97 million in net income (profit) each year or $17.57 on an earnings per share basis. Mettler-Toledo International employs 15,400 workers across the globe.

Mettler-Toledo International's mailing address is 1900 POLARIS PARKWAY, COLUMBUS OH, 43240. The medical instruments supplier can be reached via phone at 614-438-4511 or via email at [email protected]